Home›Stock Screener›Eris Lifesciences›P/E Ratio

Eris Lifesciences P/E Ratio

Current P/E Ratio
31.33
High Valuation
Very High - High growth expectations or significantly overvalued

Eris Lifesciences (ERIS) P/E ratio is 31.33 (High), EPS (TTM) ₹45.33, current price ₹1400.60 on NSE vs historical average P/E of 29.67 (55.6th percentile) — Very High - High growth expectations or significantly overvalued. See Eris Lifesciences P/B ratio trends to compare market price against book value per share.

Current Valuation Metrics

P/E Ratio 31.33
Current Price ₹1400.60
EPS (TTM) ₹45.33
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 29.67
Historical Range 19.65 - 42.0
Percentile 55.6%

Sector Context

Sector Average 55.77
Sector Median 31.44
Sector Rank #11 of 194
Sector Percentile 5.7%

Earnings Breakdown (TTM)

TTM EPS ₹44.98
Mar 2026 ₹20.60
Sept 2025 ₹8.82

ERIS P/E Ratio — Valuation Signal & Historical Context

Eris Lifesciences P/E 31.33 vs historical average 29.67, range 19.65–42.0 — signal: Overvalued. Read ERIS dividend growth for the complete payout history and dividend yield track record.

  • Stock appears overvalued with PE of 31.33, suggesting caution for new investments
  • Trading at discount to sector average PE of 55.77

Eris Lifesciences P/E Ratio Historical Trend

ERIS annual price-to-earnings ratio — 9 years, EPS and year-end price. Current P/E 31.33 vs historical average 29.67. For live price, revenue and the complete fundamental profile, see ERIS stock price BSE.

ERIS Historical P/E Ratio — EPS, Year-End Price & Valuation

Eris Lifesciences annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 42.0 31.7 ₹1331.30 NSE High
2024 37.4 24.22 ₹905.80 NSE High
2023 23.39 28.41 ₹664.65 NSE Moderate
2022 26.18 29.2 ₹764.35 NSE High
2021 20.34 29.01 ₹590.10 NSE Moderate
2020 19.65 25.26 ₹496.40 NSE Moderate
2019 32.34 21.4 ₹692.15 NSE High
2018 36.85 21.27 ₹783.85 NSE High
2017 28.88 20.76 ₹599.50 NSE High

ERIS vs Healthcare Peers — P/E Ratio Comparison

Eris Lifesciences P/E 31.33 vs Healthcare average 55.77, median 31.44 — range 2.86–916.67.

Sector Average
55.77
Sector Median
31.44
Lowest P/E
2.86
Highest P/E
916.67
Companies
194
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.61 ₹64 Low
Sunrest Lifescience SUNREST 3.76 ₹30 Low
Sun Pharma Advanced Rese… SPARC 4.76 ₹7,399 Low
Shelter Pharma SHELTER 5.23 ₹47 Low
Dipna Pharmachem DPL 5.39 ₹14 Low
JFL Life Sciences JFLLIFE 5.41 ₹68 Low
Amwill Health Care AMWILL 7.26 ₹83 Low
Zenith Drugs ZENITHDRUG 7.69 ₹84 Low
Galaxy Medicare GML 7.8 ₹27 Low